Aptargroup (ATR) Cash from Investing Activities (2009 - 2026)
Aptargroup (ATR) reported Cash from Investing Activities of -$65.1 million for Q1 2026, down 14.95% year-over-year from -$76.5 million in Q1 2025, and up 44.03% quarter-over-quarter from -$116.3 million in Q4 2025.
Aptargroup (ATR) Cash from Investing Activities (2009 - 2026) Analysis & Trends
Aptargroup (ATR) has 18 years of Cash from Investing Activities data on file, last reported at -$65.1 million in Q1 2026.
- Cash from Investing Activities for Q1 2026 came in at -$65.1 million, down 14.95% year-over-year; the trailing twelve-month figure through Mar 2026 was -$339.9 million (up 9.79% YoY), and the FY2025 annual result was -$331.4 million, up 16.46% from the prior year.
- Cash from Investing Activities grew to -$65.1 million in Q1 2026 per ATR's latest filing, from -$116.3 million in the prior quarter.
- Over five years, Cash from Investing Activities peaked at -$56.6 million in Q1 2025 and troughed at -$171.1 million in Q4 2024.
- A 5-year average of -$83.1 million and a median of -$75.7 million in 2023 frame the typical range for Cash from Investing Activities.
- The sharpest annual moves came in 2022 and 2024: Cash from Investing Activities jumped 59.64% in 2022, then sank 100.96% in 2024.
- A 5-year view of Cash from Investing Activities shows it stood at -$73.2 million in 2022, then retreated by 16.23% to -$85.1 million in 2023, then plunged by 100.96% to -$171.1 million in 2024, then soared by 32.01% to -$116.3 million in 2025, then jumped by 44.03% to -$65.1 million in 2026.
- Business Quant data shows ATR's Cash from Investing Activities at -$65.1 million in Q1 2026, -$116.3 million in Q4 2025, and -$89.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -914.50 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -139.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -96.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -58.03 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -42.70 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -77.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -90.00 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -131.58 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -133.00 Mn |
| 10 | Aptargroup | 7.72 Bn | 7.52 Bn | 351.91 Mn | -65.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -65.10 Mn |
| Mar 31, 2026 | -65.10 Mn |
| Dec 31, 2025 | -116.31 Mn |
| Dec 31, 2025 | -116.31 Mn |
| Sep 30, 2025 | -89.05 Mn |
| Sep 30, 2025 | -89.05 Mn |
| Jun 30, 2025 | -69.44 Mn |
| Jun 30, 2025 | -69.44 Mn |
| Mar 31, 2025 | -56.63 Mn |
| Mar 31, 2025 | -56.63 Mn |
| Dec 31, 2024 | -171.07 Mn |
| Dec 31, 2024 | -171.07 Mn |
| Sep 30, 2024 | -80.67 Mn |
| Sep 30, 2024 | -80.67 Mn |
| Jun 30, 2024 | -68.41 Mn |
| Jun 30, 2024 | -68.41 Mn |
| Mar 31, 2024 | -76.57 Mn |
| Mar 31, 2024 | -76.57 Mn |
| Dec 31, 2023 | -85.13 Mn |
| Dec 31, 2023 | -85.13 Mn |